ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

OVID Ovid Therapeutics Inc

3.34
0.00 (0.00%)
プレマーケット
最終更新日: 17:21:58
15分遅延
名称 銘柄コード 市場 種別
Ovid Therapeutics Inc OVID NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 3.34 17:21:58
始値 安値 高値 終値 前日終値
3.34
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0421:00GLOBEOvid Therapeutics to Present at the 23rd Annual Needham..
2024/3/0822:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0822:20EDGAR2Form 8-K - Current report
2024/3/0822:00GLOBEOvid Therapeutics Reports Business Updates, Fourth Quarter..
2024/2/2822:00GLOBEOvid Therapeutics to Present at the TD Cowen 44th Annual..
2024/2/2708:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2708:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2708:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2707:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2707:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1501:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1220:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0622:00GLOBEOvid Therapeutics to Present at the Oppenheimer 34th Annual..
2023/12/0707:08EDGAR2Form 8-K - Current report
2023/12/0121:30GLOBEOvid Therapeutics to Present Five Abstracts Supporting its..
2023/11/1614:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1606:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0405:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0321:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0321:10EDGAR2Form 8-K - Current report
2023/11/0321:00GLOBEOvid Therapeutics Reports Third Quarter 2023 Financial..
2023/10/1821:04EDGAR2Form 8-K - Current report
2023/10/1821:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
2023/10/1021:00GLOBEOvid Therapeutics to Present at the Jefferies Biotech..
2023/10/0301:15EDGAR2Form 8-K - Current report
2023/9/2620:30GLOBEOvid Therapeutics to Host Investor Event - R&D Day on..
2023/9/2020:30GLOBEOvid Therapeutics to Present at the 2023 Cantor Fitzgerald..
2023/8/3021:00GLOBEOvid Therapeutics to Participate in Upcoming September..
2023/8/0422:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0422:10EDGAR2Form 8-K - Current report
2023/8/0421:00GLOBEOvid Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0121:00GLOBEOvid Therapeutics to Present at the BTIG Virtual..
2023/8/0106:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/6/2821:00GLOBEOvid Therapeutics Expands Its Scientific Leadership Team &..
2023/6/2621:00GLOBEOvid Therapeutics Added to Russell 3000® Index
2023/5/0520:30GLOBEOvid Therapeutics Reports First Quarter 2023 Financial..
2023/5/0119:00GLOBEOvid Therapeutics Announces Collaboration with Graviton..

最近閲覧した銘柄

Delayed Upgrade Clock